USC Eye Institute

The USC Roski Eye Institute is a hospital located in Los Angeles, California. It is comprised of a full-time faculty of physicians specializing in all subspecialties of ophthalmology. With 58 employees, the institute has a revenue of $50 million. The USC Roski Eye Institute offers a wide range of services, including the diagnosis, treatment, and management of complex eye conditions across all ages. They specialize in leading research in the epidemiology of eye disease to help prevent blindness, and are recognized for their pioneering work in developing new methods to restore sight to the blind. The institute utilizes emerging technologies to provide cutting-edge care to its patients. The USC Roski Eye Institute has been ranked in the top 10 ophthalmology programs in the country for the past 26 years by both U.S. News & World Report and Ophthalmology Times. They are committed to making significant breakthroughs in ophthalmology and improving the quality of life for their patients. Some of their major achievements include changing health care policy in America through community health studies, pioneering the use of ultra-high speed Fourier domain optical coherence tomography for advanced diagnosis, inventing the world's first FDA approved artificial retina, discovering a new stem cell therapy for age-related macular degeneration, and discovering which retinal cells mutate to become retinoblastoma. For more information, please visit eye.keckmedicine.org.